BCDAW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CTCXW, SAVAW, CELUW, and CEROW
Should you be buying BioCardia stock or one of its competitors? The main competitors of BioCardia include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.
180 Life Sciences (NASDAQ:ATNFW) and BioCardia (NASDAQ:BCDAW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, community ranking, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.
In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. BioCardia's average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the media.
180 Life Sciences and BioCardia both received 0 outperform votes by MarketBeat users.
Summary
180 Life Sciences and BioCardia tied by winning 1 of the 2 factors compared between the two stocks.
Get BioCardia News Delivered to You Automatically
Sign up to receive the latest news and ratings for BCDAW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BCDAW vs. The Competition
BioCardia Competitors List
Related Companies and Tools
